| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 3 buys and 11 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $268.95M | - | |
| Dir | 390.7K | $88.82M | - | |
| CEO | 152.2K | $34.60M | - | |
| VP | 72.6K | $16.51M | - | |
| CFO | 59.6K | $13.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2017 | Treacy Paul | SVP, Technical Operations | Sell | 884 | $131.97 | $116,665.67 | -2.4% | |
| Feb 15, 2017 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $134.55 | $26,910.00 | -1.2% | |
| Jan 18, 2017 | Cox Russell J. | EVP &COO | Sell | 4,000 | $128.75 | $515,000.00 | -4.0% | |
| Jan 17, 2017 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $115.93 | $23,186.00 | -1.2% | |
| Dec 15, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $103.09 | $20,618.00 | -1.2% | |
| Dec 2, 2016 | Enright Patrick G74 | Director | Sell | 677 | $101.80 | $68,918.60 | -33.2% | |
| Nov 15, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $112.19 | $22,438.00 | -1.2% | |
| Nov 14, 2016 | O'Keefe Kenneth W63 | Director | Buy | 2,000 | $113.84 | $227,688.14 | +74.1% | |
| Oct 17, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $118.16 | $23,632.00 | -1.2% | |
| Sep 19, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $126.17 | $25,234.00 | -1.1% |